Industry Portals
Biotechnical Industry News
Integer a velit nec risus malesuada imperdiet id et odio. Nunc sit amet mauris dapibus, feugiat diam eget, suscipit, nam gravida nulla eget turpis commodo.
Young & Partners 2020 Pharmaceutical Executive Summit: Peter Marks Keynote Speech: Perspective on the Development of Vaccines and Gene Therapies
Welcoming Comments by Peter Young, CEO of Young & Partners and the Keynote Speech of Peter Marks of the FDA.
Young & Partners 2020 Pharmaceutical Executive Summit: Peter Marks Fireside Chat: The Impact of the Pandemic
Fireside Chat featuring Peter Marks of the FDA, interviewed by Dr. Stephen Spielberg, Senior Advisor, Young & Partners
Pharma Exec – Taking Pharma’s Pulse in a Tough 2020 (Young & Partners article Sept 2020)
Assessing COVID-19’s wide and varied impact on pharma and biotech business in the first half of the year, and how it shapes market prospects ahead
Debt and Equity Markets Buoyant (ICIS Chemical Business September 4 2020)
Data shows a strong debt market and solid equity issuance, but IPOs all Asian
Chemical M&A Activity Narrows (Young & Partners Article in ICIS Chemical Business August 28, 2020 issue)
This article shows how the market is performing under the effects of the pandemic
Chemical M&A and Financing Healthy, but Coronavirus Clouds the Outlook (ICIS Chemical Business Feb 14-20, 2020)
Young & Partners authored article that looks at what happened last year in M&A and Financing and the outlook for 2020.
Press Release: Société de Chimie Industrielle Elects Peter Young as President (January 23, 2020)
Leading Chemicals and Life Science industry association elects new officers for 2020
Pharmaceutical Executive “Trends to Watch” issue features Young & Partners (January 2020)
Young & Partners and others discuss the biopharma business and financial ecosystem today and going forward
Chemicals Financing Activity Declines (Y&P article in ICIS Chemical Business Nov 29 – Dec 5, 2019)
Young & Partners documents the decline in debt and equity financing and the underlying trends
Young & Partners 2019 Chemical Conference: Pierre Brondeau, CEO of FMC Fireside Chat: Dealing with Change – Perspectives on FMC and Agchem
Peter Young moderates fireside chat with CEO of FMC Corporation
Young & Partners 2019 Chemical Conference: Bob Patel, CEO, LyondellBasell Fireside Chat: Creating a Blueprint for Growth and Profitability
Peter Young moderates fireside chat with Bhavesh V. (Bob) Patel, CEO, LyondellBasell
Young & Partners 2019 Chemical Conference: Anla Cheng and Jeremy Goldkorn of SupChina: Perspectives and Update on China
Anla Cheng, Founder and CEO, SupChina, Jeremy Goldkorn, Editor-in-Chief, SupChina, moderated by Peter Young, CEO, Young & Partners
Megadeals done, M&A volumes remain flat (Chemical Week July 22, 2019 issue)
Editor-in-Chief interviews Peter Young about the Chemical M&A market developments
Pharma and Biotech – Financial Check and Outlook (Y&P article in Pharma Exec, July 2019 issue)
Young & Partners examples the strategic, M&A, and financial health of Biopharma
Chemicals M&A in Transition (Y&P article in ICIS Chemical Business, June 14-20, 2019)
Analysis of the M&A market: Shifting Valuations, Healthy Volumes, Death of Mega Deals
M&A Values Hold Strong But Volume Dips (Chemweek March 11-18, 2019)
Young & Partners data shows high total dollars in 2018, but underlying volumes slid
Chemicals M&A at Inflection Point (Y&P article in ICIS March 1-7, 2019 issue)
Transaction trends differ greatly, depending on sector and geography.
CFIUS Reform’s Impact on Biopharma (Phama Exec February 2019 issue)
What the new rules mean for Chinese-related investments and acquisitions in the US